Shefali Agarwal

Shefali Agarwal is currently the CEO and President at Onxeo S.A. Shefali has a wealth of experience in the biotechnology and pharmaceutical industry, holding various leadership roles such as EVP Chief Medical and Development Officer at Epizyme, Lead GYN Oncology Advisor at TESARO, Inc., and SVP, Head of Clinical Development at Curis. Shefali has also served as a Board Member at Gritstone bio and Fate therapeutics inc. Shefali has a strong background in conducting clinical trials in various indications including Hemophilia A, Chronic CML, and solid tumors. Shefali holds a degree in MIS from the University of Maryland and an MBBS from Bangalore University.